2Obrand DI,Gordon PH.Incidence and patterns of recurrence following curative resection for colorectal carcinoma.Dis Colon Rectum,1997,40:15-23.
3Park YJ,Park KJ,Park JG,et al.Prognostic factors in 2230 Korean colorectal cancer patients:analysis of consecutively operated cases.World J Surg,1999,23:721-726.
4Colquhoun PH,Wexner SD.Surgical management of colon cancer.Curr Gastroenterol Rep,2002,4:414-419.
5Shimada T,Kojima K,Yoshiura K,et al.Characteristics of the peroxisome proliferator-activated receptor γ (PPARγ) ligand induced apoptosis in colon cancer cells.Gut,2002,50:658-664.
6Lefebvre AM,Chen I,Desreumaux P,et al.Activation of the peroxisome proliferator activated receptor gamma promotes the development of conlon tumors in C57BL/6J-APCMin/+ mice.Nat Med,1998,4:1053-1057.
7Osawa E,Nakajima A,Wada K,et al.Peroxisome proliferator activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice.Gastroenterology,2003,124:361-367.
8Baker EA,Bergin FG,Leaper DJ.Matrix metalloproteinases,their tissue inhibitors and colorectal cancer staging.Br J Surg,2000,87:1215-1221.
9Sunami E,Tsuno NH,Kitayama J,et al.Decreased synthesis of matrix metalloproteinase-7 and adhesion to the extracellular matrix proteins of human colon cancer cells treated with troglitazone.Surg Today,2002,32:343-350.
2MURNANE MJ,CAI J,SHUJA S,et al.Active MMP-2 effectively identifies the presence of colorectal cancer[J].Int J Cancer,2009,125(12):2893-2902.
3EMARA M,CHEUNG PY,GRABOWSKI K,et al.Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers[J].Clin Chem Lab Med,2009,47(8):993-1000.
4ZAFIRELLIS K,AGROGIANNIS G,ZACHAKI A,et al.Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer[J].J Surg Res,2008,147(1):99-107.
6WERTHER K,CHRISTENSEN IJ,NIELSEN HJ.Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma[J].Br J Cancer,2002,86(3):417-423.
7CAO D,HOU M,GUAN YS,et al.Expression of HIF-1alpha and VEGF in colorectal cancer:association with clinical outcomes and prognostic implications[J].BMC Cancer,2009,10(9):432.
